Gary Wu
Gastroenterology · Philadelphia, PANPI 1275547804
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,500 of the $1,954 with a category attached, or 76.8%. Every reported general payment came from a single manufacturer, Merck. That places this record below the midpoint for gastroenterology clinicians in PA, where the typical reported total is $1,806.
Across 3 payments — averaging $651.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$2K
Across 3 payments — averaging $309,542 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$900K
- Intercept Pharmaceuticals, Inc.$29K
What the payments were for
- Consulting fees$1,50077%
- Travel & lodging$45423%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 3 | $1,954 |
How this compares
$1,954 in reported general payments places this provider in the 50th percentile of 935 gastroenterology providers in Pennsylvania.
Other gastroenterology in Philadelphia
- Michael KochmanPhiladelphia$361K
- Gary LichtensteinPhiladelphia$342K
- Gregory GinsbergPhiladelphia$234K
- Neilanjan NandiPhiladelphia$209K
- David LichtensteinPhiladelphia$192K
- Alexander SchlachtermanPhiladelphia$188K
- Kuchikala ReddyPhiladelphia$182K
- James LewisPhiladelphia$175K
- Beth GardnerPhiladelphia$122K
- Gary FalkPhiladelphia$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.